Yasmin Hashambhoy-Ramsay, Ph.D., et. al. Evaluating Biomarkers of JTX 8064 (anti LILRB2/ILT4 monoclonal antibody) in an Ex Vivo Human Tumor Histoculture System to Inform Clinical Development. Presented at the SITC Annual Meeting, November 2020.
Jounce Therapeutics, Inc.
780 Memorial Drive
Cambridge, MA 02139
Phone: (857) 259-3840
Fax: (888) 459-2940
For Investor and Media inquiries, please contact:
(857) 259-3843 firstname.lastname@example.org